Analysis from the Agriculture and Horticulture Development Board (AHDB) has found that a “rapid rise” of GLP-1 weight loss drugs has created both “challenges and opportunities” for red meat consumption.
GLP-1 medications work by suppressing appetite, slowing digestion and altering taste perception. AHDB said that this results in users typically eating less food overall, favouring smaller portions and increasingly prioritising nutrient-dense, protein-rich foods, which has “important implications” for red meat.
The YouGov/AHDB tracker February 2026 found that, of those people taking GLP-1s, 85% report eating less food overall, while 43% report eating more protein-dense foods such as meat and fish. AHDB said this evidence suggests that protein remained a dietary priority.
Vanessa Adamson, retail and consumer insight manager at AHDB, commented: “GLP-1 drugs are driving a clear shift towards ‘less but better’ eating. Although consumers may be buying smaller quantities, protein remains central to their diets, and research suggests many are willing to spend more on high-quality meat when they do purchase it.
“For red meat, this presents an opportunity to focus on lean, nutrient-dense cuts and premium products, such as steaks and pork tenderloins, that align with the health priorities of GLP-1 users, particularly protein for satiety and muscle maintenance.”
Consumers seek premium options
The trade body said that evidence from international research supported the trend. It said that a large US food demand study found that while GLP-1 users reduced overall food consumption, they showed a higher willingness to pay for high-quality meat and seafood, which AHDB said suggested a potential shift towards premiumisation rather than complete avoidance.
GLP-1 users also reported cutting back most sharply on ultra-processed, calorie-dense foods and takeaways. Looking at the potential effects on industry, AHDB said this may pose a challenge for processed meat products and some out-of-home channels, but reinforces growing consumer interest in more natural, minimally processed protein sources.
This comes as retailers have started to launch smaller portions of nutrient-dense meal options, designed to meet the needs of consumers with reduced appetites. AHDB commented that similar approaches could support red meat consumption by offering convenience, clear protein credentials and appropriate portion sizes.
Adamson concluded: “Red meat is well placed to remain part of a balanced diet for GLP-“1 users, particularly where messaging focuses on lean cuts, quality and nutritional value. The key will be meeting changing consumer needs with the right products, portions and communication.”
